DATAVANT

Serial Number 87723096
Registration 5719127
702

Registration Progress

Application Filed
Dec 15, 2017
Under Examination
Approved for Publication
Jan 22, 2019
Published for Opposition
Jan 22, 2019
Registered
Apr 9, 2019

Attorney Assistance

Important Deadline Approaching

Section 8 (6-Year) Declaration Due (Based on registration date 2019-04-09)
Due: April 09, 2025 (89 days overdue)

Grace period ends: October 09, 2025

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
87723096
Registration Number
5719127
Filing Date
December 15, 2017
Registration Date
April 9, 2019
Published for Opposition
January 22, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Mar 13, 2025
Registration
Registered
Classes
009 035 042

Rights Holder

DATAVANT, INC.

03
Address
2222 W.Dunlap Avenue, Suite 250
Phoenix, AZ 85021

Ownership History

Roivant Sciences GmbH

Original Applicant
99
4051 Basel CH

Roivant Sciences GmbH

Owner at Publication
99
4051 Basel CH

Roivant Sciences GmbH

Original Registrant
99
4051 Basel CH

DATAVANT, INC.

New Owner After Registration #1
03
Phoenix, AZ

Legal Representation

Attorney
Vanessa A. Ignacio, Esq.

USPTO Deadlines

Next Renewal Deadline
1372 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-04-09)
Due Date
April 09, 2029
Grace Period Ends
October 09, 2029

Application History

46 events
Date Code Type Description
Apr 3, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 3, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 3, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 3, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 3, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 13, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 13, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 13, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 13, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED
May 28, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 28, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 28, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 28, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 28, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 9, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 16, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 16, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 10, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 10, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 10, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 9, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 22, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 22, 2019 PUBO A PUBLISHED FOR OPPOSITION
Jan 2, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2018 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
Dec 14, 2018 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 8, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 9, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2018 GNRT O NON-FINAL ACTION E-MAILED
Nov 6, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 6, 2018 CNRT R NON-FINAL ACTION WRITTEN
Oct 4, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED
Oct 4, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN
Oct 4, 2018 GNEA O EXAMINERS AMENDMENT E-MAILED
Oct 4, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 4, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2018 ALIE A ASSIGNED TO LIE
Aug 14, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2018 GNRT F NON-FINAL ACTION E-MAILED
Feb 16, 2018 CNRT R NON-FINAL ACTION WRITTEN
Feb 16, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 10, 2018 DOCK D ASSIGNED TO EXAMINER
Jan 3, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 009
Computer software for transmitting, analyzing and generating reports; computer software for data processing in the fields of healthcare, biomedical research, and clinical trial data; computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical research, and clinical trial data; computer software for database integration in the field of healthcare; computer software for creating searchable databases of information and data in the fields of healthcare, biomedical research, and clinical trials; software for data analysis in the fields of healthcare, biomedical research, and clinical trial data
Class 035
Business research in the field of healthcare; business information services in the field of healthcare; data processing services; analysis of business data; business data analysis services in the field of biomedical research and clinical trials; business data analysis of technical data by computers; systematization and compilation of information into computer databases; business data analysis services in the fields of healthcare and biomedicine, and for clinical trials
Class 042
Scientific and technological services, namely, medical research and scientific research, chemical analysis in the healthcare and biomedical fields; scientific research; chemical analysis for industrial purposes; biomedical research services; design and development of computer hardware and software; scientific and technological services in the nature of scientific data processing analysis services; pharmaceutical and biomedical research services; providing a website for analytics purposes in the fields of biomedical research and clinical trial data; providing a website and information in the fields of biomedical research, clinical trials and clinical trial data; providing an on-line and cloud computing database in the field of biomedical research and clinical trial data; compiling data for research and scientific analysis purposes in the fields of biomedicine and clinical trials; providing scientific research information in the field of biomedicine and clinical trials; analysis in the field of scientific data relating to biomedical research and clinical trials; research and analysis services in the scientific fields of artificial intelligence and machine learning analytics for biomedical research and healthcare institutions

Classification

International Classes
009 035 042